Showing results (91-100 of 107) with videos related to

Sort By:
Pageof 11
Urologic Oncology|May 27, 2015
Clinical utility of a novel urine-based gene fusion TTTY15-USP9Y in predicting prostate biopsy outcomeYasheng Zhu, Shancheng Ren, Taile Jing, et al.
Molecular Cell|September 8, 2015
Truncated ERG Oncoproteins from TMPRSS2-ERG Fusions Are Resistant to SPOP-Mediated Proteasome DegradationJian An, Shancheng Ren, Stephen J Murphy, et al.
Nature Medicine|August 15, 2017
Intrinsic BET inhibitor resistance in SPOP-mutated prostate cancer is mediated by BET protein stabilization and AKT-mTORC1 activationPingzhao Zhang, Dejie Wang, Yu Zhao, et al.
Cell Research|February 22, 2012
RNA-seq analysis of prostate cancer in the Chinese population identifies recurrent gene fusions, cancer-associated long noncoding RNAs and aberrant alternative splicingsShancheng Ren, Zhiyu Peng, Jian-Hua Mao, et al.
Oncotarget|December 20, 2014
Development and prospective multicenter evaluation of the long noncoding RNA MALAT-1 as a diagnostic urinary biomarker for prostate cancerFubo Wang, Shancheng Ren, Rui Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 6, 2021
Single-Cell Analysis Reveals EP4 as a Target for Restoring T-Cell Infiltration and Sensitizing Prostate Cancer to ImmunotherapyShihong Peng, Pan Hu, Yu-Tian Xiao, et al.
Plos One|June 20, 2015
Age-Specific Cutoff Value for the Application of Percent Free Prostate-Specific Antigen (PSA) in Chinese Men with Serum PSA Levels of 4.0-10.0 ng/mlRui Chen, Yiran Huang, Xiaobing Cai, et al.
Nature Genetics|February 16, 2024
Multi-omic profiling of clear cell renal cell carcinoma identifies metabolic reprogramming associated with disease progressionJunyi Hu, Shao-Gang Wang, Yaxin Hou, et al.
The Journal of Clinical Investigation|June 8, 2021
FOXA1 overexpression suppresses interferon signaling and immune response in cancerYundong He, Liguo Wang, Ting Wei, et al.
Nature Communications|March 20, 2021
CRISPRi screens reveal a DNA methylation-mediated 3D genome dependent causal mechanism in prostate cancerMusaddeque Ahmed, Fraser Soares, Ji-Han Xia, et al.
Pageof 11